Washington — The Supreme Court on Monday issued an administrative order temporarily leaving access to the abortion pill mifepristone unchanged while the justices consider whether to permit restrictions imposed by a federal appeals court to take effect. Justice Samuel Alito's order prevents immediate enforcement of the appeals-court limitations and keeps pharmacy and mail distribution available. The action follows litigation filed by Louisiana challenging FDA prescribing rules and a three-judge panel of the 5th U.S. Circuit Court of Appeals that concluded the state was likely to prevail. The Supreme Court has preserved the status quo through at least Thursday as it evaluates the legal arguments, with potential further rulings expected later this week.
Prepared by Lauren Mitchell and reviewed by editorial team.
此案影响到对堕胎药米非司酮的获取。如果实施限制,可能会影响您获取该药的方式和地点。本周请关注最高法院的裁决。事关您的健康和权利。
最高法院目前维持米非司酮的获取。但未来充满不确定性。请随时了解您所在州关于堕胎权的立场。如果您认识可能受到影响的人,转发此信息非常有价值。
当最高法院发布一项临时命令,通过药房和邮寄的方式保留米非司酮的获取途径,并阻止了上诉法院限制的即时执行时,寻求药物流产的女性、药房和临床医生都受益了。
路易斯安那州和挑战FDA处方规则的原告在最高法院暂停了下级法院的限制以待进一步审查时,经历了执行这些限制的延迟。
No left-leaning sources found for this story.
No right-leaning sources found for this story.
Comments